Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 8Recruiting 2Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 91Other solid neoplasm 10Dermatologic 5Gastrointestinal 4Tumor-Agnostic 3Head & Neck 3Gynecologic 3Genitourinary 3CNS 3Sarcoma 1Myeloid 1Lymphoid 1

Conditions

Advanced Solid Tumors 1

Interventions

Cyclophosphamide 21Specimen Handling 20Magnetic Resonance Spectroscopy 20pembrolizumab 18Nivolumab 18Radiotherapy 17Biopsy 16Doxorubicin 15Temozolomide 14Radiation 14Ipilimumab 10X-Rays 9Irinotecan 9Ifosfamide 9Etoposide 9Phantoms, Imaging 8fludarabine 7cabozantinib 7Vincristine 7Carboplatin 7Bevacizumab 7regorafenib 6Sirolimus 6palbociclib 5olaparib 5durvalumab 5Vinorelbine 5Sunitinib 5Radiosurgery 5Immunoglobulin G 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Pemetrexed × Sarcoma × Clear all
NCT04185883 2025-10-22

Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

Amgen

Phase 1 Active not recruiting
610 enrolled
Other solid neoplasmSarcoma

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡